Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development.
Novartis is one of the world leaders in the healthcare industry, as well as one of the major players in every field it is engaged in. Its products are marketed in over 155 Countries around the world and reach nearly 800 million people globally.
The Group activities are organized in two divisions: Innovative Medicines (composed of two business units: Novartis Pharmaceuticals and Novartis Oncology) and Sandoz (generics and biosimilars).
About 110,000 people of more than 140 nationalities work at Novartis around the world.
With an established presence in Italy, Novartis is one of the leading pharmaceutical groups in the Country and has been one of the major players in innovation within the healthcare industry for over twenty years. In Italy, employees are more than 2,300.
Why Federated Innovation?
To support the open innovation ecosystem and for the growth of the Italian Life Sciences sector.